아이케어

비상장폐업자

eyecare Co.,Ltd

이상원

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

아이케어

Business Reg. No. 1148644198 · CEO 이상원

I.Investment Overview

Target아이케어 (1148644198)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명아이케어
영문명eyecare Co.,Ltd
대표자이상원
사업자등록번호1148644198
법인등록번호1101113226481
설립일2005.05.12
종업원수0명

V.Workforce

0

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW390.82018185.92019241.32022246.92023210.12024
영업이익100M KRW9.4201817.9201926.3202218.5202310.42024
순이익100M KRW5.7201814.5201921.8202215.720238.32024
Item20242023202220192018
자산총계84.9억원102.9억원109.3억원73.6억원182.1억원
부채총계68.2억원80.5억원82.6억원55.6억원172.6억원
자본총계16.7억원22.4억원26.7억원18억원9.5억원
매출액210.1억원246.9억원241.3억원185.9억원390.8억원
영업이익10.4억원18.5억원26.3억원17.9억원9.4억원
순이익8.3억원15.7억원21.8억원14.5억원5.7억원

VII.Financial Ratios

FY2024 basis

4.94%

영업이익률

3.96%

순이익률

9.8%

ROA

49.8%

ROE

408.02%

부채비율

19.68%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

아이케어 투심보고서 | Alpha Lenz